INTRODUCTION
The system performance initiative of the Canadian Partnership Against Cancer is the first pan-Canadian report to offer indicators for measuring treatment practice patterns by province and for comparing practice with current guidelines. The 2011 Cancer System Performance Report 1 presents data on guideline-based treatment indicators for the second year, allowing for a preliminary trend analysis. The decision to examine indicators measuring treatment practice patterns came from several workshops and consultations involving a broad range of experts and knowledge leaders from across the cancer care landscape. Among the treatment indicators examined is the percentage of resected stage ii and iii rectal cancer cases receiving neoadjuvant (preoperative) radiation therapy (rt). Neoadjuvant therapy rates were similar for men and women, but rates were lower in older patients. In the most recent year, for all provinces combined, 56% of patients less than 60 years of age received neoadjuvant rt; just 20% of patients 80 years of age and older received the same treatment (Figure 2 ).
NEOADJUVANT RT IN RESECTED RECTAL CANCER

retrospective Chart review
To better understand provincial variations in treatment patterns for early-stage rectal cancer, the Partnership is working with cancer agencies to conduct a retrospective chart review of resected rectal (and lung) cancer patients. The chart review (being conducted in Alberta, Saskatchewan, Manitoba, Prince Edward Island, and Newfoundland and Labrador) will help to identify factors that influence preoperative rt referral or treatment rates. Such factors may include comorbid conditions, performance status, other patient-related contraindications for treatment, patient choice, and clinician judgment. Information gained from the chart review will help to formulate strategies for improvements in data collection and indicator calculation and will also help to inform the development of meaningful performance targets and benchmarks in this area.
ABOUT THE CANCER SYSTEM PERFORMANCE REPORT
The Cancer System Performance Report is published by the Canadian Partnership Against Cancer and made possible through the dedicated efforts of the panCanadian Strategic Advisory and Technical Working Groups for System Performance. Pivotal in the data collection efforts are staff from the provincial cancer agencies or their equivalents, the C17 Council, the Canadian Breast Cancer Screening Database, the National Colorectal Cancer Screening Network, and the Pan-Canadian Cervical Screening Initiative. Statistics Canada provided access to data and vetted the output.
The 2011 System Performance Report can be viewed at http://www.cancerview.ca/systemperformancereport.
Public-use slides of figures in the present article and the System Performance Report can be downloaded at http://www.cancerview.ca/publicuseslides.
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